Exparel Injection, Suspension, Liposomal
Product Images NDC 65250-133
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Exparel (NDC 65250-133). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Pacira Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Exparel 02)
Figure 2 (Exparel 03)
Figure 3 (Exparel 04)
Principal Display Panel (133 mg/10 mL Vial Label)
Principal Display Panel (133 mg/10 mL Vial Carton)
Principal Display Panel (133 mg/10 mL Vial Carton)
Principal Display Panel (266 mg/20 mL Vial Label)
Principal Display Panel (266 mg/20 mL Vial Carton)
Principal Display Panel (266 mg/20 mL Vial Carton)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.